Clinical Trials Sponsored by Grupo de Estudos Multicentricos em Onco-Hematologia

Total 7 results

Grupo de Estudos Multicentricos em Onco-Hematologia

Completed

Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma

Multiple Myeloma

Brazil
Grupo de Estudos Multicentricos em Onco-Hematologia

Unknown

Iberoamerican Protocol With Thalidomide in Patients With Symptomatic Newly Diagnosed Multiple Myeloma Over 65 Years

Multiple Myeloma

Brazil
Grupo de Estudos Multicentricos em Onco-Hematologia

Unknown

Daratumumab Intensified Treatment to Eligible MM New Patients CTD-Dara Induction, Follow by Dara Consolidation (MAXDARA)

Multiple Myeloma Stage I

Brazil
Grupo de Estudos Multicentricos em Onco-Hematologia

Completed

Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation (GBRAM003r)

Multiple Myeloma | Effects of Chemotherapy
Grupo de Estudos Multicentricos em Onco-Hematologia

Completed

Clinical Trial With Clobetasol and Dexamethasone for Topical Treatment of Oral Lesions of Chronic Graft-versus-host Disease

Oral Manifestations | Graft vs Host Disease

Brazil
Grupo de Estudos Multicentricos em Onco-Hematologia
Takeda

Unknown

T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients (Tcell-Brazil)

T-cell Lymphoma | NK-Cell Lymphoma | T-cell Lymphoma Adults
Grupo de Estudos Multicentricos em Onco-Hematologia
Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Unknown

Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients

Oral Hemorrhage

Brazil

Clinical Trials Sponsored by Grupo de Estudos Multicentricos em Onco-Hematologia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Zimbabwe

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations